Study: Patients Taking Isotretinoin at Increased Risk of Ulcerative Colitis

Researchers suggest that patients taking isotretinoin are at much higher risk of inflammatory bowel disease, according to a study published in the American Journal of Gastroenterology.


The study assessed 3,664 cases of Crohn’s disease; 4,428 cases of ulcerative colitis; 97 cases of inflammatory bowel disease and 21,832 control cases. Of the total study population, 24 cases and 36 control were exposed to isotretinoin, which is used for treatment of acne.

Results showed that ulcerative colitis had a strong association with previous isotretinoin exposure. On the other hand, there was not as strong of an association between isotretinoin and Crohn’s disease.

 

Read the study about isotretinoin.

 

Read other coverage about GI conditions:

 

- Exercise, Vitamin D Keys to Reducing GI Disease, Conditions

 

- Surgeons Use Transoral Incisionless Fundoplication to Treat GERD

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers

Featured Podcast